Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Veeramani

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|November 28, 2023
AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamersDario Ruiz-Ciancio, Suresh Veeramani, Eric Embree, et al.
Molecular Therapy. Nucleic Acids|November 7, 2024
AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamersDario Ruiz-Ciancio, Suresh Veeramani, Rahul Singh, et al.
Cancer Immunology Research|August 7, 2019
An RNA Aptamer-Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma PatientsSuresh Veeramani, Sue E Blackwell, William H Thiel, et al.
The Journal of Biological Chemistry|May 26, 2010
Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growthTsai-Der Chuang, Siu-Ju Chen, Fen-Fen Lin, et al.
Blood|October 7, 2009
Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo modelSiao-Yi Wang, Suresh Veeramani, Emilian Racila, et al.
Blood|July 20, 2011
Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphismSuresh Veeramani, Siao-Yi Wang, Christopher Dahle, et al.
Oncogene|September 20, 2005
Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cellsSuresh Veeramani, Tsukasa Igawa, Ta-Chun Yuan, et al.
Endocrine-Related Cancer|April 8, 2006
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cellsTa-Chun Yuan, Suresh Veeramani, Fen-Fen Lin, et al.
Endocrine-Related Cancer|December 3, 2005
Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancerSuresh Veeramani, Ta-Chun Yuan, Siu-Ju Chen, et al.
Free Radical Biology & Medicine|May 8, 2012
Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cellsSuresh Veeramani, Yu-Wei Chou, Frank C Lin, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|November 28, 2023
AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamersDario Ruiz-Ciancio, Suresh Veeramani, Eric Embree, et al.
Molecular Therapy. Nucleic Acids|November 7, 2024
AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamersDario Ruiz-Ciancio, Suresh Veeramani, Rahul Singh, et al.
Cancer Immunology Research|August 7, 2019
An RNA Aptamer-Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma PatientsSuresh Veeramani, Sue E Blackwell, William H Thiel, et al.
The Journal of Biological Chemistry|May 26, 2010
Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growthTsai-Der Chuang, Siu-Ju Chen, Fen-Fen Lin, et al.
Blood|October 7, 2009
Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo modelSiao-Yi Wang, Suresh Veeramani, Emilian Racila, et al.
Blood|July 20, 2011
Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphismSuresh Veeramani, Siao-Yi Wang, Christopher Dahle, et al.
Oncogene|September 20, 2005
Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cellsSuresh Veeramani, Tsukasa Igawa, Ta-Chun Yuan, et al.
Endocrine-Related Cancer|April 8, 2006
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cellsTa-Chun Yuan, Suresh Veeramani, Fen-Fen Lin, et al.
Endocrine-Related Cancer|December 3, 2005
Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancerSuresh Veeramani, Ta-Chun Yuan, Siu-Ju Chen, et al.
Free Radical Biology & Medicine|May 8, 2012
Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cellsSuresh Veeramani, Yu-Wei Chou, Frank C Lin, et al.
Pageof 3